The University of Chicago Header Logo

Wendy Stock

Concepts (918)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Wendy Stock's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Wendy Stock has written about over time.
Myelodysplastic Syndromes, 18 publications between 1993 and 2022, average publication date July 2010. Transplantation Conditioning, 40 publications between 2000 and 2021, average publication date December 2010. Hematologic Neoplasms, 24 publications between 2001 and 2025, average publication date February 2012. Hematopoietic Stem Cell Transplantation, 60 publications between 1995 and 2025, average publication date August 2012. Humans, 352 publications between 1981 and 2026, average publication date July 2013. Adult, 195 publications between 1981 and 2026, average publication date July 2013. Antineoplastic Combined Chemotherapy Protocols, 72 publications between 1995 and 2025, average publication date March 2014. Neoplasm, Residual, 17 publications between 2000 and 2025, average publication date January 2015. Adolescent, 84 publications between 1981 and 2025, average publication date February 2015. Philadelphia Chromosome, 19 publications between 1994 and 2025, average publication date February 2015. Antineoplastic Agents, 46 publications between 1993 and 2025, average publication date June 2015. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 99 publications between 1994 and 2025, average publication date December 2017. Leukemia, Myeloid, Acute, 86 publications between 2004 and 2026, average publication date January 2018. Young Adult, 96 publications between 2009 and 2025, average publication date February 2018. Mutation, 38 publications between 2000 and 2025, average publication date June 2018. Azacitidine, 14 publications between 2014 and 2024, average publication date October 2019. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 9 publications between 2015 and 2023, average publication date April 2021. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 16 publications between 2014 and 2025, average publication date August 2021. Antineoplastic Agents, Immunological, 14 publications between 2019 and 2025, average publication date May 2022.

To see the data from this visualization as text, click here.
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (918)
Explore
_
Co-Authors (91)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_